Synthetic non-peptide molecules modeled after host defense peptides, designed to provide antimicrobial and anti-inflammatory effects without inducing microbial resistance.

A Ceragenin-based drug candidate designated for prevention and treatment of infections in cystic fibrosis caused by multiple pathogens including bacteria and fungi.